These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19138651)

  • 21. Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.
    Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
    Eur J Intern Med; 2009 Jul; 20(4):373-7. PubMed ID: 19524177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of point-of-care and laboratory glucose analysis in critically ill patients.
    Lacara T; Domagtoy C; Lickliter D; Quattrocchi K; Snipes L; Kuszaj J; Prasnikar M
    Am J Crit Care; 2007 Jul; 16(4):336-46; quiz 347. PubMed ID: 17595363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyslipidemia therapy update: the importance of full lipid profile assessment.
    Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
    Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International quality assurance schemes for cholesterol.
    Grafnetter D
    Scand J Clin Lab Invest Suppl; 1990; 198():32-42. PubMed ID: 2161131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
    Whitehead SJ; Ford C; Gama R
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid measurement of blood cholesterol: evaluation of a new instrument.
    Lasater TM; Lefebvre RC; Assaf AR; Saritelli AL; Carleton RA
    Am J Prev Med; 1987; 3(6):311-6. PubMed ID: 3452369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of protein on hemoglobin and hematocrit assays with a conductivity-based point-of-care testing device: comparison with optical methods.
    Hopfer SM; Nadeau FL; Sundra M; Makowski GS
    Ann Clin Lab Sci; 2004; 34(1):75-82. PubMed ID: 15038671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia.
    Baker AM; Klein RL; Moss KL; Haeri S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):293.e1-4. PubMed ID: 19631926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of cholesterol, triglycerides, and HDL using compact analysis systems.
    Warnick GR
    Clin Lab Med; 1989 Mar; 9(1):73-88. PubMed ID: 2647378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point of care testing.
    Nichols JH
    Clin Lab Med; 2007 Dec; 27(4):893-908, viii. PubMed ID: 17950904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride: a pilot study.
    Puavilai W; Laorugpongse D; Deerochanawong C; Muthapongthavorn N; Srilert P
    J Med Assoc Thai; 2009 Feb; 92(2):182-7. PubMed ID: 19253792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of lidocaine on the COBAS INTEGRA.
    Liu-Allison LY; Hui RA; Schwenzer KS
    Ann Clin Lab Sci; 1997; 27(2):105-15. PubMed ID: 9098509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resident training in point-of-care testing.
    Campbell S; Howanitz PJ
    Clin Lab Med; 2007 Jun; 27(2):397-410; abstract viii. PubMed ID: 17556092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calibration as a source of imprecision in cholesterol testing. Ramifications for patient risk classification.
    Epstein HD; Nipper HC; Horowitz GL
    Arch Pathol Lab Med; 1990 Apr; 114(4):399-402. PubMed ID: 2322099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.
    Faergeman O; Holme I; Fayyad R; Bhatia S; Grundy SM; Kastelein JJ; LaRosa JC; Larsen ML; Lindahl C; Olsson AG; Tikkanen MJ; Waters DD; Pedersen TR;
    Am J Cardiol; 2009 Aug; 104(4):459-63. PubMed ID: 19660594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.
    Charach G; Kaysar N; Grosskopf I; Rabinovich A; Weintraub M
    J Clin Pharmacol; 2009 Jul; 49(7):848-51. PubMed ID: 19553406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The current method of handling of test samples and medical reimbursement for POCT in Japan].
    Shimetani N
    Rinsho Byori; 2002 Oct; 50(10):958-64. PubMed ID: 12451675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.